Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs Luma Health Co

boostAGErx
Graded #183

Lower grade

vs+8
Luma Health Co
Graded #60

Higher grade

The verdict

Luma Health Co takes it — 74.8/100 to 66.8/100.

Luma Health Co grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Luma Health Co is a nurse-practitioner-led virtual weight-loss and wellness clinic founded by Tiffani McKnight, FNP-C.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +6
74
68
Dose & formulationboostAGErx +8
77
69
Clinical oversightLuma Health Co +9
74
83
Labs & monitoringLuma Health Co +45
52
97
FulfillmentLuma Health Co +1
69
70
Contract termsLuma Health Co +30
25
55
boostAGErx · left barLuma Health Co · right bar

The numbers

MetricboostAGErxLuma Health Co
WeighScore66.8/10074.8/100
GradeCC
Scorecard rank#183#60
Semaglutide$95/mo (starting dose, compounded)$120/mo (plus a separate fee, compounded)
Tirzepatide$95/mo (starting dose, compounded)$180/mo (compounded)
CoverageCoverage not published30 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #183 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
  • Compounded medications are non-refundable once dispensed
  • Pharmacy partner not named on the site
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
Luma Health Co

Graded #60 · C

Strengths

  • Transparent, competitive pricing published up front — compounded semaglutide from $120/mo, tirzepatide from $180/mo, retatrutide from $170/mo
  • No subscription, monthly fee or membership — a direct-to-patient model where you pay per medication, and follow-up visits are free
  • Free initial consults for first responders, law enforcement, military, nurses and teachers ($0), and $25 for other healthcare workers
  • Founded and led by a named family nurse practitioner (Tiffani McKnight, FNP-C) licensed across 30 states/DC, with HIPAA-compliant virtual visits
  • HSA/FSA funds and financing accepted, with itemized invoices for HSA/FSA submission

Where it loses points

  • Offers compounded retatrutide (labeled "RTT/GLP-3"), an investigational triple agonist not FDA-approved — a higher-risk, less-studied option
  • Compounded medications only — no brand-name Wegovy, Zepbound or Ozempic — and compounded GLP-1s aren't FDA-reviewed or approved
  • No LegitScript certification shown and no compounding-pharmacy partner named, so the dispensing pharmacy can't be independently verified
  • Small, newly established founder-led practice with a thin website and limited public track record or third-party reviews
  • Medication prices are "starting at" and billed on top of a one-time consult fee, so the true first-month cost runs higher than the headline

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard